Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
The FDA finalized a rule to oversee lab-developed tests as if they were medical devices, prompting lawsuits. Opponents said ...
In recording, Makary said little about specific plans for his agency or about the layoffs that have roiled his workforce.
Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the ...
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Employees across the U.S. Department of Health and Human Services began receiving notices of dismissal Tuesday, as part of a ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
Hundreds of thousands of Target brand canned vegetables were recently recalled by the Food and Drug Administration (FDA) in nearly two dozen states. Good & Gather, Target's store brand ...
After spending nine months on the International Space Station, NASA astronauts Suni Williams and Butch Wilmore have finally made it home. The duo splashed down off the Florida coast aboard ...
Some products had low or no levels detected. "We look forward to seeing the details of how they intend to implement the plan, and we hope the FDA is providing adequate resources and staffing to ...
Management reiterated expectations for FDA approval of LNZ100 by August 2025 ... in the August 2025 PDUFA date and Q4 2025 launch plans. Strategic focus shifted more heavily towards commercial ...
Alnylam's Amvuttra first to treat both nerve and heart forms of ATTR-CM Pricing strategy crucial for Amvuttra's market share against oral options Alnylam is banking on the success of the drug ...